Uncategorized

The hidden cost of FDA unpredictability

Published

on

When the variance can’t be modeled, even disciplined biotech investors stop deploying. Here’s the cheapest fix for biotech’s investability problem.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version